Navigation Links
Biologics Don't Raise Cancer Risk in Rheumatoid Arthritis Patients
Date:10/28/2008

Review finds no connection between drugs that block tumor necrosis factor and malignancies

TUESDAY, Oct. 28 (HealthDay News) -- TNF-antagonists, drugs widely used to treat rheumatoid arthritis (RA), don't appear to cause cancer, say Spanish researchers who analyzed data on more than 4,000 RA patients treated with the biologics.

These drugs, which have been used since 1998 and given to more than 600,000 people worldwide, interfere with biologic substances that cause or worsen inflammation in RA patients. But it's been unclear whether blocking TNF (tumor necrosis factor) increases the risk of cancer, according to background information in an American College of Rheumatology (ACR) news release about the study.

Some studies have suggested an association between RA and certain types of cancer, including lung and blood cancers, but the reasons for this increased risk are uncertain.

The data in this new study came from a drug registry called BIOBADASER, established in 2001 for long-term follow up of the safety of biological therapies in RA patients. The 4,529 RA patients treated with TNF-antagonists were compared with RA patients who didn't receive the drugs.

After they adjusted for age, sex, and RA duration/activity, the researchers found that the rate of cancer in the TNF group was very close to that of the non-TNF group (0.92 percent). Based on this, they concluded that TNF use isn't associated with an increased risk of developing cancer.

"Despite foreseen fears, blocking the tumor necrosis factor does not make patients more prone to develop cancer. All on the contrary, blocking the inflammation cascade may help diminish the overall risk of cancer in these patients," Dr. Loreto Carmona, director of the research unit at the Spanish Foundation of Rheumatology, said in the news release.

The study was presented Monday at the ACR annual meeting, in San Francisco.

More information<
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. Cell Therapeutics, Inc. (CTI) Plans to Submit Supplemental Biologics License Application (sBLA) for ZEVALIN(R) Consolidation of First Remission in Advanced Stage Follicular Lymphoma in 2008
2. CalbaTech Reports That LifeStems Biologics License Has Been Renewed
3. Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG
4. Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference
5. AstraZeneca - Biologics Day Interviews With Senior Management
6. In Post-Vioxx Era, Biologics are Reviving the Arthritis Treatment Market
7. Humira to Replace Remicade as First Choice Among Biologics for the Treatment of Crohns Disease
8. Growing Link Between Diabetes and Periodontal Disease Focus of National Gathering for Health Care Leaders
9. Treating your periodontal pockets may benefit your pocket book
10. Ortho Organizers(R) Announces the Launch of the Ancor Pro(TM) Orthodontic Anchorage System Hands-on Course
11. Survey confirms Americans prefer root canal treatment by endodontists
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Biologics Don't Raise Cancer Risk in Rheumatoid Arthritis Patients
(Date:5/6/2015)... 06, 2015 vcfo, a specialized consulting ... and operational support to optimize business performance and productivity, ... Lynch and Michael Scheaffer. Both Lynch and Scheaffer have ... experience. , “We are delighted to add Jack ... CEO. “Leveraging their background in financial management and leadership, ...
(Date:5/6/2015)... 2015 Follow us on LinkedIn ... driven by the rising consumer awareness over the importance ... diseases. Hand washing is becoming a part of personal ... contracting infections. Periodic outbreak of Avian flu, Swine flu, ... virus disease (EVD) epidemic in West Africa are ...
(Date:5/6/2015)... California (PRWEB) May 06, 2015 In March, ... presenting at the 8th Milano Masterclass. As Europe’s most ... most elite plastic surgeons. Dr. Batniji was hand chosen ... Facial Plastic and Reconstructive Surgery, Dr. Pietro Palma. ... Milan, Italy. The conference hosts a diverse, multi-national faculty; ...
(Date:5/6/2015)... The 2015 STEMtech conference exhibition hall floor ... booth selection . Don’t miss this opportunity to highlight ... university decision-makers from around the country. , This year’s ... Arizona Grand in Phoenix. This beautiful all-suite hotel is ... of the South Mountain Preserve. The Phoenix area offers ...
(Date:5/6/2015)... Norcross, GA (PRWEB) May 06, 2015 ... has chosen Hexagon Geospatial technology to manage and distribute ... , Australia is one of the driest continents on ... supply through times of drought and erratic seasonal rainfalls ... water supply solutions. , Water NSW manages raw water ...
Breaking Medicine News(10 mins):Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 2Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 3Health News:Growing Apprehension Amid Disease Outbreaks Drives Global Sales of Hand Sanitizers, According to a New Report by Global Industry Analysts, Inc. 4Health News:California Surgeon Speaks at International Rhinoplasty Conference 2Health News:STEMtech Conference Exhibitors Gain Access to Community College and University Representatives From Across the U.S. 2Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 2Health News:Water NSW Unlocks Imagery and Elevation Data Archive Across the Enterprise using Hexagon Geospatial Solutions 3
... WYE ) announced today that it will ... January 14, 2009 at 11:30 a.m. Eastern Time. ... and Pharmaceutical Business Units, Wyeth Pharmaceuticals. Wyeth,s presentation will ... and available for replay following the conference.Wyeth is one ...
... Jan. 8 (Nasdaq: WHRT ... has submitted an Investigational Device Exemption ("IDE") application to ... "Agency") for a pivotal Bridge-to-Transplant ("BTT") study of the ... includes detailed device information, including design and in ...
... We hear it everywhere: "What is your carbon footprint?" ... how can you reduce yours? It isn,t all that ... planning to bring it down.Listen to this report from Siemens ... can access video, audio, text, graphics and photos for free ...
... desk to prevent obesity: ovarian cancer. , ... ... has been set off by the medical community warning of America,s ... Cancer Institute completed a study that has shown a statistically significant ...
... been one of the most amazing recovery cases I have ... Otolaryngology, Dallas, TX , DALLAS, Jan. 8 In ... was laid off at Christmas and diagnosed with advanced stage ... I had cancer," says Hogland, tears welling up in his ...
... & Science University,s School of Dentistry ( www.ohsu.edu/sod ) ... and blood pressure synthesize a molecule known to be ... could someday play a significant role in the prevention ... pressure. According to the National Institutes of Health, SIDS ...
Cached Medicine News:Health News:Wyeth to Present at the JP Morgan Healthcare Conference 2Health News:WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD 2Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 2Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 3Health News:One Man's Determined Journey to Remission and a Renewed Sense of Faith 2Health News:OHSU School of Dentistry team discovers new molecule in blood-pressure control system 2
(Date:5/6/2015)... -- Fibich, Leebron, Copeland, Briggs & Josephson is pleased ... reached to resolve lawsuits involving individuals who were allegedly ... manufactured by Takeda Pharmaceuticals - has been associated with ... the firm,s attorneys were instrumental in the coordination and ... - Founding Partner of Fibich, Leebron, Copeland, Briggs ...
(Date:5/6/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/rd24gk/chromatography ) ... (Instruments and Reagents) Global Market - Forecast to ... Chromatography is an analytical technique, a method of ... mixture by differential movement through a two phase ... chromatography as an esoteric art, which mainly involves ...
(Date:5/6/2015)... 2015 NVSSoft, a Dubai ... a "Cool Vendor" by top IT research firm Gartner in ... Gartner defines a "Cool Vendor" as a company that ... The report highlights that, "as innovation gains ground ... markets should look at local technologies and services, which may ...
Breaking Medicine Technology:Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2Global Chromatography (Instruments and Reagents) Market 2015 - Forecasts to 2019 2UAE-Based Software Developer Named by Gartner as a Cool Vendor 2UAE-Based Software Developer Named by Gartner as a Cool Vendor 3UAE-Based Software Developer Named by Gartner as a Cool Vendor 4
... Alere Inc. (NYSE: ALR ) announced today ... notes due 2018 through a private placement, subject to market ... from the offering for working capital and other general corporate ... commence immediately, will be to qualified institutional buyers in reliance ...
... (Nasdaq: PCYC ) today reported financial results for its ... During the fiscal year ended June 30, 2010, total ... in the fiscal year ended June 30, 2009.  The GAAP net ... $15.0 million, or $0.31 per share. This compares to a GAAP ...
Cached Medicine Technology:Alere Inc. Announces Offering of $350 Million of Senior Subordinated Notes 2Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 2Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 3Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 4Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 5Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 6Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 7Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 8Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 9Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 10Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 11Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 12Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 13Pharmacyclics Reports Financial Results for Fiscal 2010 and for Fourth Quarter 2010 14
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: